Non-invasive aesthetic treatment is a medical practice that involves few or no incisions on the skin, leaving no visible marks afterward. The growing concern that adults have with their appearance has recently led to an increase in the demand for aesthetic procedures that do not involve invasive surgery. Fillers and injectables such as the well-known brand Botox are gaining more and more popularity, particularly among women of this age group who are in the younger half of the age range.
Non-invasive cosmetic procedures have several advantages over invasive surgical procedures, including shorter recovery times, reduced levels of discomfort and surgical wounds, reduced scarring, quicker wound healing, smaller incisions, and fewer complications. In addition, the currently available minimally invasive surgical procedures have a higher success rate and produce better outcomes when compared to more conventional surgical practices.
Permanent cosmetic procedures such as fillers, implants, fat grafting, and lip enhancements are gaining popularity. These procedures are known as "permanent cosmetic operations." Fillers are among the most common substances used in cosmetic procedures because of their low risk of adverse effects and allergic responses and the ease with which the body can tolerate them. Fillers include things like hyaluronic acid and poly-L lactic acid as some examples. Photorejuvenation, nonsurgical fat reduction, botulinum toxin fillers, and hyaluronic acid fillers were found to be the leading and most popular non-invasive aesthetic procedures, according to the same poll.
According to projections made in the World Population Prospects 2019 report, by the year 2050, the proportion of people over the age of 65 will have increased to one in six across the globe, up from one in eleven in 2019. The number of people aged 65 and older across the globe was estimated to be 703 million in 2019. It is anticipated that this number will surpass 1.5 billion by 2050. The growing population around the world is expected to create tremendous opportunities for the global non-invasive aesthetic treatment market over the forecast period.
North America is the most significant shareholder in the global non-invasive aesthetic treatment market and is anticipated to grow at a CAGR of 13.65% over the forecast period. The increasing prevalence of skin cancer and other skin conditions, such as eczema and rosacea, and the growing popularity of cosmetic operations, are some of the primary drivers of market expansion in this particular sector. The market is anticipated to expand as improved treatment options, such as laser treatments to improve one's visual appeal, become more widely used.
Europe is expected to grow at a CAGR of 15.60%, generating USD 51,060.61 million during the forecast period. The participation of developed European economies such as Germany and the United Kingdom, which are significant market participants for non-invasive European non-invasive aesthetic procedures, accounts for the size of the market. Europe is one of the world's most developed regions, resulting in superior medical facilities and patient care as a direct consequence of the region's access to cutting-edge technologies and robust infrastructure. The region is anticipated to grow at a good pace over the forecast period due to the presence of trained experts already established there and the increased population of older adults.
The global non-invasive aesthetic treatment market's major key players are Hologic, Inc., Allergan, Inc., Galderma S.A., Alma Lasers, Syneron Candel, Johnson & Johnson, MerzPharma, Lumenis, Solta Medical, Cutera Inc., and Revance Therapeutics Inc.